Key points are not available for this paper at this time.
Low doses of DMOG trigger exosomes to exert enhanced proangiogenic activity in cell-free therapeutic applications.
Share your take
Add a clinician perspective alongside expert commentary.
Liang et al. (2019) studied this question.